Objectives

Ideaz optimized the device for low volume production

Journey

We started with a mechanical layout from our client and made some simple but meaningful modifications to ensure the configuration was suitable for a low volume casing process that eliminated the need for injection molded tooling costs and lead times.

Result

Shortly after the device made its public debut, CyVek was purchased by BioTechne for $60 million in cash—with up to $195 million once milestones were met. Working closely with the engineers at CyVek and focusing on user needs, Ideaz was able to help CyVek achieve rapid commercial success and a great ROI.

Let's connect